Risk Management for Pharmaceutical Companies Under FDA's Q9 Guidance

November 15, 2019
Previous
GAMP®5: A Risk-based Approach to Compliant GxP Computerized Systems
GAMP®5: A Risk-based Approach to Compliant GxP Computerized Systems

This white paper provides an overview of GAMP 5 guidelines and explains the five-step risk management proce...

Next Flipbook
MasterControl Risk™
MasterControl Risk™

Unify all risk-related activities and documentation in a single repository, providing an accurate picture o...